X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (708) 708
male (350) 350
female (349) 349
hypertension, pulmonary - drug therapy (324) 324
pulmonary hypertension (319) 319
index medicus (314) 314
infusions, intravenous (256) 256
middle aged (255) 255
adult (247) 247
continuous intravenous epoprostenol (228) 228
iloprost (215) 215
double-blind (197) 197
treatment outcome (191) 191
prostacyclin (188) 188
iloprost - administration & dosage (179) 179
therapy (177) 177
hypertension, pulmonary - physiopathology (172) 172
aged (171) 171
inhaled iloprost (171) 171
cardiac & cardiovascular systems (168) 168
pulmonary arterial hypertension (157) 157
respiratory system (153) 153
vasodilator agents - therapeutic use (146) 146
survival (141) 141
iloprost - therapeutic use (139) 139
antihypertensive agents - therapeutic use (135) 135
vasodilator agents - administration & dosage (121) 121
epoprostenol - administration & dosage (119) 119
epoprostenol - therapeutic use (119) 119
prostacyclin analog (119) 119
hypertension (118) 118
drug therapy (117) 117
pharmacology & pharmacy (114) 114
bosentan (104) 104
animals (103) 103
arterial-hypertension (103) 103
medicine, general & internal (103) 103
care and treatment (97) 97
drug therapy, combination (93) 93
epoprostenol (92) 92
epoprostenol - analogs & derivatives (91) 91
hypertension, pulmonary - etiology (91) 91
inhaled nitric-oxide (91) 91
hypertension, pulmonary - diagnosis (90) 90
scleroderma (86) 86
sildenafil (83) 83
treprostinil (83) 83
antihypertensive agents - administration & dosage (82) 82
intravenous epoprostenol (82) 82
endothelin receptor antagonists (80) 80
injections, intravenous (79) 79
long-term treatment (79) 79
calcium-channel blockers (78) 78
rheumatology (78) 78
infusion (76) 76
placebo-controlled trial (76) 76
administration, inhalation (74) 74
surgery (73) 73
time factors (72) 72
medicine & public health (71) 71
disease (70) 70
intravenous iloprost (68) 68
systemic sclerosis (68) 68
dose-response relationship, drug (67) 67
hypertension, pulmonary - therapy (66) 66
sildenafil citrate (66) 66
endothelin-receptor antagonist (63) 63
retrospective studies (63) 63
risk factors (63) 63
scleroderma, systemic - complications (63) 63
pulmonary arteries (62) 62
oral sildenafil (61) 61
peripheral vascular disease (57) 57
systemic-sclerosis (57) 57
hemodynamics - drug effects (56) 56
mortality (56) 56
administration, oral (55) 55
combination therapy (55) 55
controlled-trial (55) 55
endothelin (55) 55
nitric oxide (55) 55
prognosis (55) 55
hemodynamics (54) 54
patients (54) 54
adolescent (53) 53
prospective studies (53) 53
research (53) 53
pediatrics (52) 52
critical care medicine (51) 51
follow-up studies (50) 50
internal medicine (50) 50
nitric-oxide (50) 50
child (49) 49
diagnosis (48) 48
familial primary pulmonary hypertension (48) 48
hypertension, pulmonary - mortality (48) 48
raynaud disease - drug therapy (48) 48
scleroderma, systemic - drug therapy (47) 47
bosentan therapy (45) 45
health aspects (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (820) 820
German (40) 40
French (23) 23
Russian (9) 9
Spanish (7) 7
Italian (5) 5
Japanese (5) 5
Turkish (2) 2
Danish (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2002, Volume 347, Issue 5, pp. 322 - 329
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2008, Volume 51, Issue 2, pp. 161 - 169
Journal Article
Journal Article
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2017, Volume 76, Issue Suppl 2, p. 901
Backgroundevaluate the effectiveness on Raynaud's phenomenon and on digital ulcers, safety and side effects, during intravenous infusion of iloprost therapy in patients with diffuse and limited... 
Hypertension | Side effects | Intravenous administration | Raynaud disease | Ulcers | Scleroderma | Patients | Pulmonary hypertension | Smoking
Journal Article
Journal Article
Journal Article
Heart and Vessels, ISSN 0910-8327, 12/2017, Volume 32, Issue 12, pp. 1488 - 1497
...). The aim of this study was to retrospectively evaluate the effect of inhaled milrinone versus inhaled iloprost in patients with persistent pulmonary hypertension following discontinuation of CPB... 
Biomedical Engineering | Cardiopulmonary bypass | Medicine & Public Health | Cardiac Surgery | Vascular Surgery | Inhaled vasodilators | Cardiology | Pulmonary vascular resistance | Pulmonary hypertension | SURGERY | CARDIAC SURGICAL-PATIENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | PRELIMINARY EXPERIENCE | INTRAVENOUS MILRINONE | RIGHT-VENTRICULAR DYSFUNCTION | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | HEART-TRANSPLANT CANDIDATES | AEROSOLIZED MILRINONE | RANDOMIZED-CONTROLLED TRIAL | Echocardiography, Transesophageal | Iloprost - administration & dosage | Follow-Up Studies | Cardiopulmonary Bypass - adverse effects | Humans | Middle Aged | Administration, Inhalation | Hypertension, Pulmonary - physiopathology | Male | Milrinone - administration & dosage | Treatment Outcome | Arterial Pressure - physiology | Dose-Response Relationship, Drug | Aged, 80 and over | Vascular Resistance - drug effects | Female | Aged | Hypertension, Pulmonary - drug therapy | Retrospective Studies | Hypertension, Pulmonary - etiology | Postoperative Complications | Vasodilator Agents - administration & dosage | Heart Diseases - surgery | Surgical clinics | Coronary artery bypass | Comparative analysis | Vasodilators | Cardiac patients | Heart | Hypertension | Respiratory therapy | Drugs | Weaning | Pulmonary arteries | Patients | Vasodilation | Pulmonary artery | Inhalation | Side effects | Blood pressure | Ventricle | Respiration | Heart diseases | Bypasses
Journal Article